Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × Interventional × NSCLC × Clear all

Phase

Status

Unknown 29 Recruiting 28 Completed 20 Not yet recruiting 16 Terminated 10 Active not recruiting 8 Withdrawn 3 Suspended 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 35 Prostatic Neoplasms 23 Breast Neoplasms 23 Colorectal Neoplasms 18 Carcinoma, Non-Small-Cell Lung 16 Neoplasm Metastasis 15 Lung Neoplasms 14 Pancreatic Neoplasms 13 Melanoma 13 Brain Neoplasms 13 Leukemia, Myeloid, Acute 12 Glioblastoma 12 Ovarian Neoplasms 10 Stomach Neoplasms 9 Carcinoma, Hepatocellular 9 Myelodysplastic Syndromes 8 Multiple Myeloma 8 Glioma 8 Triple Negative Breast Neoplasms 7 Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Carcinoma, Renal Cell 7 Leukemia 6 Rectal Neoplasms 5 Pain 5 Lymphoma, Large B-Cell, Diffuse 5 Lymphoma 5 Head and Neck Neoplasms 5 Esophageal Neoplasms 5 Uterine Cervical Neoplasms 4 Motor Activity 4

Interventions

HM781-36B 1 Docetaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05378763 2026-02-18

PINNACLE

Spectrum Pharmaceuticals, Inc

Phase 3 Suspended

NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡